Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Ortho describes bacterial HPK inhibitors as antibacterial agents

Oct. 16, 1997

KRM-1648: a rifamycin derivative active against H. pylori and Mycobacterium spp.

Oct. 15, 1997

Echinocandin antifungal agent tested in patients

Oct. 15, 1997

Natural compound for combatting fungal infections disclosed

Oct. 15, 1997

Millennium reaches milestones in discovery of antibacterial drug targets

Oct. 15, 1997

Phase I/II results reported for lobucavir in HBV

Oct. 15, 1997

Genome Therapeutics reaches milestone in alliance with Schering-Plough

Oct. 14, 1997

Merrem I.V.: a safe and effective option for bacterial meningitis

Oct. 14, 1997

New antimalarial combination launched this week in second market

Oct. 14, 1997

S-4661 efficacy demonstrated in RTI, UTI

Oct. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...